Middle East & Africa Foot and Mouth Disease Vaccine Market to grow with a CAGR of 5.96% through 2028

Increasing Incidences of Zoonotic Diseases is expected to drive the Middle East & Africa Foot and Mouth Disease Vaccine Market in the forecast period 2024-2028.

According to TechSci Research report, “Foot and Mouth Disease Vaccine Market – Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, the Middle East & Africa Foot and Mouth Disease Vaccine Market is valued at USD 90.45 million and is expected to grow with a CAGR of 5.96% through the forecast period. Also the market is expected to reach 125.48 million by 2028. This growth is driven by a thriving agricultural sector, where livestock farming is pivotal to the country's economy. The increasing demand for dairy and meat products necessitates the protection of livestock, particularly cattle, from diseases like FMD.

The escalating incidences of zoonotic diseases in the Middle East and Africa have spurred a surge in demand for Foot and Mouth Disease (FMD) vaccines. Zoonotic diseases, which are transmitted from animals to humans, pose a significant threat to both public health and the livestock industry. The recognition of this dual risk has catalyzed efforts to fortify livestock health through comprehensive vaccination programs.

Zoonotic diseases, such as FMD, not only jeopardize the health and well-being of animals but also have the potential to impact human populations indirectly. This interconnectedness between animal and human health underscores the urgency to implement effective vaccination strategies. By safeguarding livestock against diseases like FMD, we create a crucial barrier against the transmission of zoonotic pathogens to humans, thereby mitigating the risk of outbreaks and epidemics.

Furthermore, the increasing urbanization and population growth in the Middle East and Africa have led to greater human-animal interactions. This intensification in proximity between humans and livestock amplifies the potential for disease transmission. Effective vaccination against FMD becomes paramount in this context, as it acts as a preemptive measure to halt the spread of the virus within animal populations, reducing the likelihood of human exposure.

Additionally, the economic repercussions of zoonotic outbreaks cannot be understated. FMD, in particular, can result in substantial economic losses due to reduced meat and milk production, restrictions on livestock trade, and the cost of disease control measures. Recognizing the financial impact of such outbreaks, governments and stakeholders in the region are increasingly investing in comprehensive vaccination programs to safeguard both public health and the livelihoods of those dependent on agriculture and livestock farming.

However, high storage costs for vaccines are expected to slow down the growth of the market in the coming years. Maintaining the efficacy and potency of vaccines requires strict adherence to specific temperature ranges during storage and transportation. However, in many parts of the region, particularly in remote or underserved areas, ensuring reliable cold chain infrastructure can be a formidable task. The cost of establishing and maintaining proper cold storage facilities for vaccines is substantial. This includes the expenses related to refrigeration equipment, temperature monitoring systems, backup power sources, and training for personnel handling the vaccines. In regions with limited resources and infrastructure, such as rural areas or conflict-affected areas, these costs can pose a significant financial burden on healthcare providers and governments.

Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on "Middle East & Africa Foot and Mouth Disease Vaccine Market.”

Middle East & Africa Foot and Mouth Disease Vaccine Market segmentation is based on Type, Animal Type, By Company, and Region.

Some of the major companies operating in the Middle East & Africa Foot and Mouth Disease Vaccine Market include:

• Bioveta Middle East
• Biovac
• Onderstepoort Biological Products SOC Ltd
• Vaxxinova Middle East and Africa
• Boehringer Ingelheim
• MAS Company
• Laboratoires Biové

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Certain regions, particularly the Saudi Arabia, are projected to exert significant demand for Foot and Mouth Disease Vaccine worldwide. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhancing their Foot and Mouth Disease Vaccine productivity each year, are expected to contribute to a remarkable growth of the Middle East & Africa Foot and Mouth Disease Vaccine Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Middle East & Africa Foot and Mouth Disease Vaccine Market, By Type (Conventional Vaccine, Emergency Vaccine), By Animal Type (Cattle, Sheep and Goat, Pigs, Others), By Country, By Competition, Forecast & Opportunities, 2028F has evaluated the future growth potential of Middle East & Africa Foot and Mouth Disease Vaccine Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Middle East & Africa Foot and Mouth Disease Vaccine Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com